Key result
CRT 'super-responders' had excellent long-term outcomes, though 14.5% experienced cardiac events over a mean follow-up of 68 months.
Why the study?
What is the long-term incidence of cardiac events in heart failure patients who are 'super-responders' to cardiac resynchronization therapy?
Cohort (n=259)
Yes
What is the long-term incidence of cardiac events in heart failure patients who are 'super-responders' to cardiac resynchronization therapy?
CRT super-responders have excellent long-term outcomes, but appropriate CRT-D interventions can still occur despite normalized LVEF, highlighting the need for continued monitoring.
Answers are grounded in this paper and cite their sources.
Residual event risk in CRT super-responders warrants ongoing surveillance; extends response durability data yet leaves open risk stratification.
AIMS: To evaluate the long-term changes of clinical and echocardiographic parameters, the incidence of cardiac events and parameters associated with late cardiac events in 'super-responders' to cardiac resynchronization therapy (CRT) with [CRT defibrillator (CRT-D)] or without defibrillator back-up. METHODS AND RESULTS: In all consecutive patients treated with CRT in two Italian centres (Trieste and Udine) with left ventricular ejection fraction (LVEF) ≤0.35 at implantation (Timp) and LVEF > 0.50 1 and/or 2 years (Tnorm) after implantation, the long-term outcome and the evolution of echocardiographic parameters were assessed; factors associated with a higher risk of cardiac events, defined as hospitalization or death for heart failure (HF), sudden death, or CRT-D appropriate interventions, were also analysed. Among the 259 patients evaluated, 62 (24%) had LVEF ≥ 0.50 at Tnorm (n = 44 with at 1 year, n = 18 at 2 years). During a mean follow-up of 68 ± 30 months, one cardiac death (for HF) and eight cardiovascular events (two hospitalization for HF and six appropriate CRT-D interventions) occurred. At the last echo evaluation (Tfup) performed 51 ± 26 months after Timp, LVEF was <0.50 in five patients (>0.45 in four of them). At univariable analysis, only LV end-systolic volume evaluated at Tfup was associated with a higher risk of cardiac events during follow-up. CONCLUSION: In 'super-responders' to CRT long-term outcome is excellent. However, cardiac events, mainly CRT-D appropriate interventions, can occur despite the persistence of LVEF > 0.50. Early identification of these patients is still an unsolved issue.
No takes yet. Share an insight, caveat, or question.
Zecchin et al. (2013) conducted a cohort in Heart failure (n=259). Cardiac resynchronization therapy (CRT) 'super-responder' status was evaluated on Cardiac events (hospitalization or death for heart failure, sudden death, or CRT-D appropriate interventions). CRT 'super-responders' had excellent long-term outcomes, though 14.5% experienced cardiac events over a mean follow-up of 68 months.
Synapse has enriched 10 related papers. Consider them for comparative context: